← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2010Last known activity
May 31, 2026
Timeline
2010s
- Jan 1, 2010
PrECOG, LLC.— Founded
Drugs by trial phase (38 distinct, 20 trials)
Phase 3 (13 own, 0 via acquisition)
Phase 2 (23 own, 0 via acquisition)
Indications
Studied for
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Cholangiocarcinoma
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lung Neoplasms
- Lymphoma
- Lymphoma, Follicular
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Mesothelioma
- Multiple Myeloma
- Neoplasms, Plasma Cell
- Plasmacytoma
- Recurrence
- Urinary Bladder Neoplasms
Recent trials (21)
- NCT07285239Lead sponsorPhase 3May 31, 2026
- NCT07057791Lead sponsorPhase 2Dec 31, 2025
- NCT04334759Lead sponsorPhase 3Sep 30, 2020
- NCT04215146CollaboratorPhase 2Mar 31, 2020
- NCT03834688Lead sponsorPhase 2Jul 31, 2019
- NCT03836209Lead sponsorPhase 2Jul 31, 2019
- NCT03532451Lead sponsorPhase 1Oct 31, 2018
- NCT03323151Lead sponsorPhase 1/Phase 2Aug 13, 2018
- NCT03113422Lead sponsorPhase 2Oct 1, 2017
- NCT02947685CollaboratorPhase 3Jun 30, 2017
- NCT02899195Lead sponsorPhase 2Jun 13, 2017
- NCT02713828Study chairPhase 1/Phase 2Apr 10, 2016
- NCT02713828Lead sponsorPhase 1/Phase 2Apr 10, 2016
- NCT02513394CollaboratorPhase 3Aug 1, 2015
- NCT02181634Lead sponsorPhase 2Dec 9, 2014
Details
- Founded
- Boulder, CO, US Jan 1, 2010
- Last known activity
- May 31, 2026